Stockscreener 앱 받기
37.47
1.26%
-0.48
시간 외 거래:
37.47
전일 마감가:
$37.95
열려 있는:
$37.64
하루 거래량:
231.10K
Relative Volume:
0.54
시가총액:
$1.82B
수익:
$441.33M
순이익/손실:
$9.76M
주가수익비율:
187.54
EPS:
0.1998
순현금흐름:
$839.00K
1주 성능:
+3.91%
1개월 성능:
+2.97%
6개월 성능:
-9.78%
1년 성능:
+62.77%
1일 변동 폭
$37.42
$38.25
1주일 범위
$35.23
$39.14
52주 변동 폭
$22.22
$48.25
Artivion Inc Stock (AORT) Company Profile
명칭
Artivion Inc
전화
(770) 419-3355
주소
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
37.47 | 1.84B | 441.33M | 9.76M | 839.00K | 0.1998 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-10 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2025-08-13 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2025-06-17 | 개시 | Canaccord Genuity | Buy |
| 2024-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-27 | 재확인 | Lake Street | Buy |
| 2022-08-08 | 개시 | Lake Street | Buy |
| 2022-03-03 | 개시 | Stifel | Buy |
모두보기
Artivion Inc 주식(AORT)의 최신 뉴스
Assessing Artivion (AORT) Valuation After FDA Approval Of NEXUS Aortic Arch System - simplywall.st
Ladenburg Thalmann upgrades Artivion (AORT) - MSN
Artivion secures FDA approval for NEXUS aortic arch device, weighs Endospan acquisition - MSN
Artivion Inc (AORT) Shares Surge 3.1% -- What GF Score of 85 Tel - GuruFocus
Endospan’s FDA nod for Nexus brings acquisition by Artivion closer - BioWorld News
Growth Value: Is Artivion Inc a momentum stock2026 Growth vs Value & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Artivion Receives FDA Clearance for NEXUS Aortic Arch System - Bitget
Artivion Secures FDA Approval for NEXUS Aortic Arch System - Zacks Investment Research
Artivion (AORT) Soars 5.3%: Is Further Upside Left in the Stock? - Yahoo Finance
UnitedHealth, Alignment Healthcare, Humana And Other Big Stocks Moving Higher On Tuesday - Sahm
Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know - Yahoo Finance
Artivion, Inc. (AORT) Stock forecasts - Yahoo Finance UK
FDA Greenlights Artivion's (AORT) Nexus Aortic Arch System - GuruFocus
Stocks making big moves yesterday: Levi's, Strategy, Vishay Precision, Celsius, and Artivion - Yahoo Finance
Artivion (AORT) Receives "Buy" Rating Reiteration from Needham | - GuruFocus
Needham reiterates Artivion stock rating on FDA approval By Investing.com - Investing.com South Africa
Needham reiterates Artivion stock rating on FDA approval - Investing.com
Artivion stock gets FDA approval for NEXUS stent graft system By Investing.com - Investing.com Australia
Artivion stock gets FDA approval for NEXUS stent graft system - Investing.com
FDA approves Artivion’s NEXUS system for aortic arch disease - Investing.com
Needham Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $58 - Moomoo
FDA approves Artivion’s NEXUS system for aortic arch disease By Investing.com - Investing.com South Africa
Artivion Says FDA Approves NEXUS Aortic Arch System, Secures Option to Acquire Endospan - marketscreener.com
Artivion announces U.S. FDA approval of the Nexus® aortic arch system - marketscreener.com
Artivion Announces U.S. FDA Approval Of The Nexus® Aortic Arch System - TradingView — Track All Markets
Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System - ChartMill
Analyst Downgrade: What is the long term forecast for Artivion Inc stockWeekly Profit Analysis & Reliable Breakout Forecasts - baoquankhu1.vn
Why Artivion (AORT) Stock Is Down Today - Yahoo Finance
Artivion Inc (AORT) Trading Down 3.24% on Apr 6 - GuruFocus
SG Americas Securities LLC Raises Stake in Artivion, Inc. $AORT - MarketBeat
Artivion, Inc. (AORT) stock price, news, quote and history - Yahoo Finance UK
Artivion, Inc. (AORT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Holloway Jean F, Artivion SVP, sells $83k in shares - Investing.com
Artivion Inc Com (AORT) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Artivion (NYSE:AORT) Shares Gap DownShould You Sell? - MarketBeat
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks - Yahoo Finance
JPMorgan Chase & Co. Has $5.17 Million Position in Artivion, Inc. $AORT - MarketBeat
Is It Too Late To Consider Artivion (AORT) After A 161.6% Three Year Rally? - Yahoo Finance
How The Artivion (AORT) Narrative Is Shifting After A Trimmed Target And Steady Fair Value - Yahoo Finance
Artivion, Inc. (AORT) Stock Forecasts - Yahoo Finance
EDGAR Filing Documents for 0001999371-26-007510 - SEC.gov
Artivion (AORT) details 2026 virtual meeting, director slate and Say on Pay - Stock Titan
[ARS] ARTIVION, INC. SEC Filing - Stock Titan
Artivion (NYSE:AORT) Shares Down 6.6%What's Next? - MarketBeat
Take Profit: Will Artivion Inc stock go up in YEAR2026 Earnings Impact & Short-Term Swing Trade Alerts - baoquankhu1.vn
Artivion Inc (AORT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.40%
0.00%
자본화:
|
볼륨(24시간):